Skip to content
AnalystLens
Back to MRNABalance Sheet

Moderna, Inc. Total Liabilities 2017-2026 | MRNA

Annual FY2017–FY2025 · quarterly through Q1 FY2026

Latest annual · FY2025

$3.69B

+13.8%YoY vs FY2024Source: 10-KFY2025

From $459.2M in FY2017 to $3.69B in FY2025: 8.0× in 8 years.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY26$4.1B+54.7%Not reportedNot reportedNot reported
FY25$2.6B−32.6%$2.6B−34.2%$2.8B−27.6%$3.7B+13.8%
FY24$3.9B−25.7%$4.0B−19.6%$3.9B−35.3%$3.2B−29.1%
FY23$5.3B−50.0%$4.9B−38.8%$6.0B−25.7%$4.6B−32.1%
FY22$10.5B+18.9%$8.1B−14.7%$8.1B−25.3%$6.7B−36.0%

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionStable
CAGR

−5.0%

FY2020
$4.78B
FY2025
$3.69B

5 years selected · on the chart

Total Liabilities History

Year-over-year comparison from 10-K annual reports

  1. $3.69B
YoY changeLargest recent move+1051.9%in FY20Latest +13.8%

1 older move runs past ±150% (largest +1051.9%); point at, tap or drag across the bars to read one.

Total Liabilities, period by period

PeriodValueChangeSource
FY2025$3.69B+13.8%10-K
FY2024$3.24B−29.1%10-K
FY2023$4.57B−32.1%10-K
FY2022$6.74B−36.0%10-K
FY2021$10.52B+120.4%10-K
FY2020$4.78B+1051.9%10-K
FY2019$414.6M−4.0%10-K
FY2018$431.9M−5.9%10-K
FY2017$459.2M—10-K

What is total liabilities?

Total liabilities can be defined as the sum of all current and non-current debts and obligations owed by the company.

What is Moderna, Inc.'s current total liabilities?

Moderna, Inc. (MRNA) annual total liabilities for 2025 was $3.69B, a 13.79% increase from 2024. Moderna, Inc. total liabilities for the quarter ending March 31, 2026 was $4.08B.

What was Moderna, Inc.'s total liabilities in 2024?

Moderna, Inc. annual total liabilities for 2024 was $3.24B, a 29.11% decline from 2023.

What was Moderna, Inc.'s total liabilities in 2023?

Moderna, Inc. annual total liabilities for 2023 was $4.57B, a 32.12% decline from 2022.

What is Moderna, Inc.'s 5-year total liabilities CAGR?

Moderna, Inc. total liabilities grew at a compound annual growth rate (CAGR) of 5.04% from FY2020 to FY2025, going from $4.78B to $3.69B over 5 years.

Company
Moderna, Inc.
Ticker
MRNA
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)